OliPass is always collaborating to develop new ways to give a happy and healthy existence for everyone on the planet. OliPass Corporation is dedicated to changing people's perceptions of life sciences and improving their quality of life.

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years. Hanmi has been successful for a few decades with high flexibility, continuously changing its market/development strategy from first generics to IMD & FDC (Incrementally Modified Drug and Fixed Dose Combination) to new drug development including innovative small molecules and biologics. During the period of significant changes, Hanmi made multiple strategic collaboration relationships with multinational companies and biotech companies. Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories. As the only Asian company with significant presence both in Korea and China, as the most R&D focused company with number of clinical stage projects with competitiveness, and as the company with open innovation based on multiple development/marketing collaborations, Hanmi is trying to develop and provide differentiated treatment options to patients suffering from various disease.

China State Institute of Pharmaceutical Industry is a company headquartered in Shanghai, China and ultimately controlled by the Government of China. The firm regulates pharmaceutical companies.

Daiichi Sankyo Company, Limited engages in the research, development, manufacture, import, sale, and marketing of pharmaceutical products. The company offers prescription drugs, OTC drugs, and quasi-drugs. Its principal products include Olmetec, Rezaltas, Calblock, and Mevalotin for cardiovascular diseases; Cravit for infectious diseases; Loxonin for bone/joint diseases; and Urief for urological diseases. The company also offers vaccines. In addition, the company is developing products for various diseases, which are under various clinical trial stages. Further, it manufactures and sells cosmetics, medical equipment, food, and beverages, as well as veterinary medicines; and manufactures active pharmaceutical ingredients and intermediates. Daiichi Sankyo primarily operates in Japan, North America, Europe, and India. The company is headquartered in Tokyo, Japan.

Apros Therapeutics, Inc., part of Kontafarma China Holdings Ltd., is an American company located in San Diego, CA. The firm engages in research and development of tumor treatments and immunotherapy. It was founded in 2016 by Tom YH Wu and Andrew T. Miller.\nThe company says this about itself: Founded in 2016, and based in San Diego, CA, Apros Therapeutics is focused on the discovery and development of tissue-targeted TLR7 agonists for the immunotherapy of cancer and infectious diseases. Apros Therapeutics has employed a chemistry-based platform to develop a portfolio of small molecule TLR7 agonists using a variety of proprietary approaches with the aim of restricting drug distribution, controlling half-life and dose in specific tissues. Each development candidate is engineered to exert precise spatiotemporal bio-distribution to target a tumor/tissue type, in order to uncouple efficacy from systemic toxicity. This platform ultimately aims to widen the therapeutic window and extend the application of innate immune agonists to treat a broad range of cancer and infectious disease indications. Apros Therapeutics is currently advancing multiple candidates into clinical development.

Henan Jinpeiko Medical Equipment Co., Ltd., established on 2019-07-22, The scope of business includes the first,two,Sales and leasing of Class III medical devices;Sales:cosmetic,Daily necessities,Office Supplies,Disinfectant(Excluding hazardous chemicals),Chemical Products(Except flammable, explosive and poisonous dangerous chemicals),Edible produce,Health Equipment,Glass product,Optical Instruments,Water purification equipment,laboratory equipment,chemical agent,cleaning supplies,teaching equipment,Electrical Equipment,Logistics equipment,Computer hardware and software,Healthy food;Automobile sales and after-sales service;road general cargo transportation;Loading and unloading service;Business Information Consulting Service;Conference Services;Exhibition display service;Health Management Consulting Services;Business Management Consulting Services;Medical device technical consultation,Technical Services;Medical Equipment Repair;Housing rental business.

The Research Institute at Nationwide Children's Hospital is one of America's ten largest free-standing pediatric research centers and works to enhance the health of children by engaging in research.

Hebei Yiran Biotechnology Co., Ltd., established on 2011-06-22, Business scope includes general items:Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);Sales of packaging products;Exhibition display service;Realtor;Machinery and Equipment Leasing.licensed items:Probiotics,edible lactic acid bacteria,Technical research and development of formula food for special medical purposes,technical consulting,production and sales;Food technology research and development,production and sales;Technical research and development of traditional Chinese medicine preparations,technical consulting,Production(Prohibited,Except for restricted items)and sales;Health food technology research and development,production and sales;Technology research and development of confectionary products,production and sales;Technology research and development of beverages and solid beverages,technical consulting,production and sales;Technology research and development of pet food,technical consulting,Production(Prohibited,Except for restricted items)and sales;feed,Technology research and development of feed additives and feed ingredients,Production(Prohibited,Except for restricted items)and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)(Except those involving the implementation of special access management measures stipulated by the state)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Zhoushan Jingjing Aquatic Products Co., Ltd., established on 2015-05-25, Business scope includes sales of aquatic products;earthwork excavation;Sea food research and development,Production;Mechanical Design,Production.

Kromnigon develops imaging technology for advanced multicolor microscopy.

Guangdong Wenbang Biotechnology Co., Ltd., established on 2015-10-19, Business scope includes food additive manufacturing,wholesale,retail;Food Science and Technology Research Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Biotechnology Extension Services;Condiment Wholesale;Bulk Food Wholesale,retail;Wholesale Prepackaged Food,retail;Wholesale of non-alcoholic beverages and tea,retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Fujian Yuanjingzhi State Biotechnology Co., Ltd., established on 2019-08-26, Business scope includes biotechnology extension services;feed processing;Agricultural technology extension service(Production and operation of crop seeds not included);Other unspecified technology promotion and application service industries;Sewage Treatment and Its Reuse;water pollution control;Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Other unspecified wholesale business(Does not include business items subject to permit approval);New material technology promotion service;Other technical promotion services;Air Pollution Control;Solid Waste Treatment(Items not subject to permit approval);Indoor Environmental Management;Other unlisted pollution control;Manufacture of organic fertilizers and microbial fertilizers;Other fertilizer manufacturing;Recycling of renewable resources(Does not contain solid waste,Hazardous Waste,Projects requiring approval from relevant departments, such as scrapped cars);feed retail;Other unspecified retail trade(Items not subject to permit approval);Agricultural Science Research and Experimental Development;internet sales;other agricultural services.

Sekisui Chemical Co., Ltd. engages in the manufacture of high-performance plastics for medical, automotive, and information technology industries; and residential housing construction. It operates through the following segments: Housing, Environment and Lifeline, High Performance Plastics, Medical, and Others. The Housing segment handles the construction, sale, and renovation of housing units. It also provides real estate and housing services. The Environment and Lifeline segment offers PVC pipes and fittings, pipe rehabilitation materials, reinforced plastic composite pipes, and synthetic wood. The High-Performance Plastics segment sells interlayer films for laminated glass, foamed polyolefin, tapes, fine particles for liquid crystals, photosensitive materials, and functional resins for infrastructure materials. The Medical segment covers clinical diagnostic reagents, clinical testing equipment, active pharmaceutical ingredients and intermediates. The Others segment covers film-type lithium-ion batteries. The company was founded on March 3, 1947 and is headquartered in Osaka, Japan.

Guangzhou Nordrich Cosmetics Co., Ltd., established on 2010-04-20, Business scope includes import and export of goods(Excluding franchised products);Cosmetic Manufacturing;Business Management Consulting Services;Wholesale of cosmetics and hygiene products;Technology Import and Export;Soap and synthetic detergent manufacturing;Retailing of cosmetics and hygiene products;Operation of non-licensed medical devices;the medical,Medical Consulting Services(Does not involve a medical diagnosis,Treatment and Rehabilitation Services);Biomedical Technology Research;Medical technology research and development;Medical technology promotion service;Medical Technology Consulting,communication service;Medical supplies and equipment retail(Does not contain drugs and medical devices);

Shandong Delong Enterprise Management Consulting Co., Ltd., established on 2017-04-17, Business scope includes general items:Business Management Consulting;Daily necessities sales;internet sales(Except for products that require a license for sale);food sales(Only sell prepackaged food);Cosmetics Wholesale;Sales of hygiene products and single-use medical products;Cosmetics Retail;Personal Hygiene Sales;Clothing and apparel wholesale;Clothing and apparel retail;Sales of Class I Medical Devices;Conference and Exhibition Services;marketing planning;market survey(Does not include foreign investigations);Health Consulting Services(Does not include medical services);Educational Consulting Services(Education and training activities that do not include licensing approval);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Internet information service;food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Qingdao Derunke Biotechnology Co., Ltd., established on 2019-11-21, Business scope includes technology research and development in the field of biomedicine,technical consulting,Technical Services,technology transfer,Technology Promotion;Research and development of new fertilizer technology and technology transfer;Technology research and development in the field of traditional Chinese medicine;feed technology development,technical consulting,Technical Services,technology transfer;Import and export of goods and technology(no publications);Food additive technology research and development;Research and development of feed additive technology,Technology Promotion,Technical Services,technical consulting;Technology development in the field of cosmetics,Technology Promotion,Technical Services,technical consulting,technology transfer;Technology development of biotechnology and products,technical consulting,technology transfer,Technology Promotion,Technical Services;research and development:Chemical Products(Does not contain dangerous goods);Wholesale and retail:cosmetic,Chemical Products(Does not contain dangerous goods).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Leases intangible assets

Liaoning Zhongke Xingguang New Material Co., Ltd., established on 2021-09-23, Business scope includes general items:Manufacture of non-metallic mineral products,Manufacture of graphite and carbon products,synthetic material manufacturing(Free of Hazardous Chemicals),Manufacture of special ceramic products,New material technology research and development,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,New material technology promotion service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)